Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Targeting neurosteroids may help prevent drug relapse.

Gunja has potential for hair growth, fertility control, immune support, and more, but needs careful handling due to toxicity.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

18β-glycyrrhetinic acid from licorice root is good for skin and hair treatments but has absorption challenges.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Glutamic acid helps increase hair growth in mice.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Topical eye β-blockers may cause hair loss.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

EGCG may help regrow hair by inhibiting a specific enzyme.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

New technologies improve diagnosis and treatment of digestive disorders.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Antiandrogens help improve developmental delays caused by valproic acid in rats.